531 results on '"Drulovic, Jelena"'
Search Results
2. Beneficial therapeutic plasma exchange response in the treatment of severe relapses in patients with multiple sclerosis
3. Exclusive breastfeeding may be a protective factor in individuals with familial multiple sclerosis. A population registry-based case-control study
4. Eyebrow alopecia associated with cladribine treatment for multiple sclerosis
5. Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers
6. Impact of the autonomic dysfunction on the quality of life in people with NMOSD and MS: An international cross-sectional study
7. Occurrence of malignant diseases in patients with multiple sclerosis: population-based MS Registry data
8. D-dimer elevation after first alemtuzumab administration in a multiple sclerosis patient: case report
9. Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants
10. Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers
11. Impact of Fenebrutinib Treatment on MRI Outcomes and Cerebrospinal Fluid Penetrance in Multiple Sclerosis: Results from the Phase II FENopta Study (S31.004)
12. Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study
13. Transverse myelitis following COVID-19: Insights from a multi-center study and systematic literature review
14. Application of deep-learning to the seronegative side of the NMO spectrum
15. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
16. Clinical predictivity of thalamic sub-regional connectivity in clinically isolated syndrome: a 7-year study
17. The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data
18. Antibodies in sera from multiple sclerosis patients recognize Trichinella spiralis muscle larvae excretory–secretory antigens
19. Exclusive breastfeeding may be a protective factor in individuals with familial multiple sclerosis. A Population Registry-based case-control study
20. The impact of the comorbid seizure/epilepsy on the health related quality of life in people with multiple sclerosis: an international multicentric study
21. Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
22. Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from Serbia
23. Epidemiology, diagnosis and management of sexual dysfunction in multiple sclerosis
24. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study
25. Gait pattern in patients with different multiple sclerosis phenotypes
26. The impact of betaplus program on patient treatment satisfaction with interferon beta-1b in multiple sclerosis: Multicentric cross-sectional survey in the western Balkan countries
27. Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing–remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up
28. Cross-cultural adaptation and validation of the disease specific questionnaire OQLQ in Serbian patients with malocclusions
29. Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers
30. Bladder dysfunction in multiple sclerosis: a 6-year follow-up study
31. Editorial: Comorbidity in multiple sclerosis and related disorders.
32. Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity
33. Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder: Do They Share Common Targets?
34. Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study
35. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5‐year study
36. Effectiveness of rehabilitation in multiple sclerosis relapse on fatigue, self-efficacy and physical activity
37. The Rao’s Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population
38. Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatment
39. Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study
40. Exploring in-vivo brain microstructural damage in multiple sclerosis through T1w/T2w-ratio mapping: a multicenter study (P14-4.009)
41. Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Interim Safety and Efficacy Results from the Phase 3 EVOLVE-MS-1 Study (P7-4.008)
42. MR T2-relaxation time as an indirect measure of brain water content and disease activity in NMOSD
43. In utero exposure to maternal anti–aquaporin-4 antibodies alters brain vasculature and neural dynamics in male mouse offspring
44. Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome
45. Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis: Case report and literature review
46. Real-World Operation of Multiple Sclerosis Centres in Central-Eastern European Countries Covering 107 Million Inhabitants
47. COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders
48. Heroin-induced acute longitudinally extensive transverse myelopathy
49. Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders
50. Validation and Cross-Cultural Adaptation of the Disease-Specific Questionnaire MSQOL-54 in Serbian Multiple Sclerosis Patients Sample
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.